Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer
Clinical trial NCT03243838 · COMPLETED
Trial details
- NCT number
- NCT03243838
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2021-10-13
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.